Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

TYMS underexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

TYMS expression (1)

TYMS overexpression + HR positive (1)

TYMS overexpression (0)

TYMS expression (1)

TYMS overexpression + HR positive (1)

TYMS overexpression (0)

›

TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3
TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	arfolitixorin Sensitive: C3 – Early Trials arfolitixorin Sensitive : C3	arfolitixorin Sensitive: C3 – Early Trials arfolitixorin Sensitive : C3
TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
TYMS underexpression	Soft Tissue Sarcoma	TYMS underexpression	Soft Tissue Sarcoma	cisplatin + pemetrexed Sensitive: C3 – Early Trials cisplatin + pemetrexed Sensitive : C3	cisplatin + pemetrexed Sensitive: C3 – Early Trials cisplatin + pemetrexed Sensitive : C3